VOYA Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-43,366
| Closed | -$165K | – | 2711 |
|
|
2020
Q1 | $165K | Hold |
43,366
| – | – | ﹤0.01% | 2202 |
|
|
2019
Q4 | $221K | Buy |
43,366
+7,074
| +19% | +$37.4K | ﹤0.01% | 2339 |
|
|
2019
Q3 | $183K | Hold |
36,292
| – | – | ﹤0.01% | 2268 |
|
|
2019
Q2 | $224K | Sell |
36,292
-188
| -0.5% | -$906 | ﹤0.01% | 2242 |
|
|
2019
Q1 | $169K | Hold |
36,480
| – | – | ﹤0.01% | 2316 |
|
|
2018
Q4 | $153K | Buy |
36,480
+5,132
| +16% | +$26.1K | ﹤0.01% | 2299 |
|
|
2018
Q3 | $197K | Buy |
31,348
+1,384
| +5% | +$10.6K | ﹤0.01% | 2342 |
|
|
2018
Q2 | $241K | Sell |
29,964
-3,530
| -11% | -$26.9K | ﹤0.01% | 2277 |
|
|
2018
Q1 | $250K | Sell |
33,494
-2,163
| -6% | -$14.4K | ﹤0.01% | 2207 |
|
|
2017
Q4 | $212K | Hold |
35,657
| – | – | ﹤0.01% | 2315 |
|
|
2017
Q3 | $262K | Hold |
35,657
| – | – | ﹤0.01% | 2245 |
|
|
2017
Q2 | $242K | Buy |
35,657
+3,920
| +12% | +$28.9K | ﹤0.01% | 2302 |
|
|
2017
Q1 | $300K | Hold |
31,737
| – | – | ﹤0.01% | 2048 |
|
|
2016
Q4 | $274K | Hold |
31,737
| – | – | ﹤0.01% | 2116 |
|
|
2016
Q3 | $201 | Hold |
31,737
| – | – | ﹤0.01% | 2291 |
|
|
2016
Q2 | $134K | Hold |
31,737
| – | – | ﹤0.01% | 2405 |
|
|
2016
Q1 | $138K | Hold |
31,737
| – | – | ﹤0.01% | 2324 |
|
|
2015
Q4 | $195K | Hold |
31,737
| – | – | ﹤0.01% | 2286 |
|
|
2015
Q3 | $182K | Sell |
31,737
-9,076
| -22% | -$69.6K | ﹤0.01% | 2307 |
|
|
2015
Q2 | $304K | Sell |
40,813
-4,328
| -10% | -$26.2K | ﹤0.01% | 2258 |
|
|
2015
Q1 | $270K | Hold |
45,141
| – | – | ﹤0.01% | 2293 |
|
|
2014
Q4 | $341K | Hold |
45,141
| – | – | ﹤0.01% | 2185 |
|
|
2014
Q3 | $234K | Hold |
45,141
| – | – | ﹤0.01% | 2413 |
|
|
2014
Q2 | $195K | Hold |
45,141
| – | – | ﹤0.01% | 2574 |
|
|
2014
Q1 | $185K | Hold |
45,141
| – | – | ﹤0.01% | 2508 |
|
|
2013
Q4 | $241K | Hold |
45,141
| – | – | ﹤0.01% | 2427 |
|
|
2013
Q3 | $227K | Hold |
45,141
| – | – | ﹤0.01% | 2437 |
|
|
2013
Q2 | $201K | Buy |
+45,141
| New | +$203K | ﹤0.01% | 2492 |
|
Other funds holding PGNX
VOYA Investment Management's PGNX Position: Q2 2020 in Review
VOYA Investment Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 43,366 shares — an estimated $165K sold.
VOYA Investment Management first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $341K in Q4 2014. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- VOYA Investment Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- VOYA Investment Management sold 43,366 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $165K.
- VOYA Investment Management first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
- VOYA Investment Management's Progenics Pharmaceuticals Inc position peaked at $341K in Q4 2014.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on VOYA Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.